Vladimir Zakharov explains how DataFrames serve as a vital tool for data-oriented programming in the Java ecosystem. By ...

The big medical news of 2026 is about the big blockbuster drug of 2025. Semaglutide (a.k.a. Ozempic, a.k.a. Wegovy) is now off patent in Canada. In the U.S. and the rest of the world, patent ...

Danish drug maker Novo Nordisk is preparing to introduce a new version of its blockbuster drug Ozempic to compete with cheaper generics that became legal on Monday, but which are not expected to hit ...

Drug companies in Canada are allowed to make lower priced generic versions of the blockbuster drug Ozempic as of next week, but experts say patients shouldn’t expect it to be available for at least a ...

A new analysis has raised concerns about the Cigna Group’s drug pricing strategy, finding that one of its subsidiaries, Quallent Pharmaceuticals, often charges more for generic medications than ...

US Securities and Exchange Commission Chair Paul Atkins says the new listing standards will reduce barriers to access digital asset products and give investors more choice. ”This approval helps to ...

According to the Association for Accessible Medicine’s 2024 U.S. Generic and Biosimilar Medicines Savings Report, the use of Food and Drug Administration-approved generic and biosimilar medicines ...

Generic brands, sometimes referred to as "private label" or "store brands," are increasingly popular today as shoppers face rising food prices in grocery stores. Some consumers believe these brands to ...

Apotex has launched the first generic version of Tasigna ® (nilotinib capsules). Nilotinib is a kinase inhibitor indicated for the treatment of adult and pediatric patients aged 1 year and older with ...